25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ORXOY (Orexo) Stock Analysis
Buy, Hold or Sell?

Let's analyze Orexo together

I guess you are interested in Orexo AB ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Orexo’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Orexo’s Price Targets

I'm going to help you getting a better view of Orexo AB ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Orexo AB ADR

I send you an email if I find something interesting about Orexo AB ADR.

1. Quick Overview

1.1. Quick analysis of Orexo (30 sec.)










1.2. What can you expect buying and holding a share of Orexo? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.49
Expected worth in 1 year
$-1.17
How sure are you?
38.2%

+ What do you gain per year?

Total Gains per Share
$-0.68
Return On Investment
-45.9%

For what price can you sell your share?

Current Price per Share
$1.48
Expected price per share
$1.475 - $1.475
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Orexo (5 min.)




Live pricePrice per Share (EOD)
$1.48
Intrinsic Value Per Share
$12.36 - $15.00
Total Value Per Share
$11.87 - $14.51

2.2. Growth of Orexo (5 min.)




Is Orexo growing?

Current yearPrevious yearGrowGrow %
How rich?-$16.9m$8.8m-$16.4m-215.7%

How much money is Orexo making?

Current yearPrevious yearGrowGrow %
Making money-$5.4m-$1.9m-$3.5m-65.0%
Net Profit Margin-34.3%-11.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Orexo (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Orexo?

Welcome investor! Orexo's management wants to use your money to grow the business. In return you get a share of Orexo.

First you should know what it really means to hold a share of Orexo. And how you can make/lose money.

Speculation

The Price per Share of Orexo is $1.475. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Orexo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Orexo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.49. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Orexo.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-3.3%-0.16-10.8%-0.07-4.8%-0.13-9.0%-0.14-9.6%-0.04-2.7%
Usd Book Value Change Per Share-0.11-7.2%-0.17-11.5%-0.05-3.5%-0.12-8.4%-0.14-9.6%-0.01-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-7.2%-0.17-11.5%-0.05-3.5%-0.12-8.4%-0.14-9.6%-0.01-1.0%
Usd Price Per Share1.48-1.76-1.10-1.61-2.92-2.73-
Price to Earnings Ratio-7.64--4.22--5.78--4.63--6.44--1.41-
Price-to-Total Gains Ratio-13.88--12.21-27.58--4.61--17.49--2.66-
Price to Book Ratio-3.01-0.76-5.13-2.97-3.07-2.53-
Price-to-Total Gains Ratio-13.88--12.21-27.58--4.61--17.49--2.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.475
Number of shares677
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.17-0.14
Usd Total Gains Per Share-0.17-0.14
Gains per Quarter (677 shares)-114.48-96.29
Gains per Year (677 shares)-457.92-385.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-458-4680-385-395
20-916-9260-770-780
30-1374-13840-1156-1165
40-1832-18420-1541-1550
50-2290-23000-1926-1935
60-2747-27580-2311-2320
70-3205-32160-2696-2705
80-3663-36740-3081-3090
90-4121-41320-3467-3475
100-4579-45900-3852-3860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%12.022.00.035.3%12.022.00.035.3%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%13.021.00.038.2%13.021.00.038.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%13.021.00.038.2%13.021.00.038.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Orexo AB ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.106-0.169+59%-0.051-52%-0.124+17%-0.142+34%-0.014-86%
Book Value Per Share---0.490-0.221-55%0.255-292%0.247-298%0.755-165%0.957-151%
Current Ratio--1.7311.782-3%1.493+16%1.765-2%2.007-14%2.071-16%
Debt To Asset Ratio--1.3051.131+15%0.903+45%0.945+38%0.817+60%0.746+75%
Debt To Equity Ratio---7.739-100%9.951-100%7.332-100%5.121-100%3.798-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---21448270.000-15022504.185-30%-42643340.000+99%-28140384.062+31%16119457.683-233%38461370.448-156%
Eps---0.048-0.159+230%-0.071+48%-0.132+174%-0.142+194%-0.039-19%
Ev To Sales Ratio---0.350-0.247-29%-0.659+88%-0.439+25%0.247-242%0.512-168%
Free Cash Flow Per Share--0.1000.012+738%-0.057+158%-0.060+160%-0.122+222%-0.110+210%
Free Cash Flow To Equity Per Share--0.1000.012+738%-0.117+217%-0.085+186%-0.106+207%-0.105+205%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15.002----------
Intrinsic Value_10Y_min--12.364----------
Intrinsic Value_1Y_max--0.014----------
Intrinsic Value_1Y_min--0.012----------
Intrinsic Value_3Y_max--1.176----------
Intrinsic Value_3Y_min--1.100----------
Intrinsic Value_5Y_max--3.707----------
Intrinsic Value_5Y_min--3.343----------
Market Cap50895170.0000%50895170.00060556635.815-16%37955720.000+34%55380849.272-8%100793141.683-50%94165706.814-46%
Net Profit Margin---0.109-0.343+216%-0.117+8%-0.270+148%-0.301+177%-0.111+2%
Operating Margin----0%-0.0510%-0.1200%-0.1670%-0.0260%
Operating Ratio--1.1771.360-13%1.206-2%1.383-15%1.386-15%1.192-1%
Pb Ratio-3.0110%-3.0110.762-495%5.132-159%2.970-201%3.073-198%2.526-219%
Pe Ratio-7.6360%-7.636-4.217-45%-5.778-24%-4.629-39%-6.442-16%-1.408-82%
Price Per Share1.4750%1.4751.755-16%1.100+34%1.605-8%2.921-50%2.729-46%
Price To Free Cash Flow Ratio3.6900%3.6900.978+277%-11.493+411%-2.541+169%-4.135+212%-2.158+158%
Price To Total Gains Ratio-13.8750%-13.875-12.210-12%27.582-150%-4.605-67%-17.495+26%-2.657-81%
Quick Ratio--0.7870.907-13%0.692+14%0.982-20%0.821-4%0.706+11%
Return On Assets---0.030-0.083+176%-0.022-28%-0.052+71%-0.047+55%-0.017-43%
Return On Equity----0.3710%-0.2310%-0.2980%-0.2230%-0.1050%
Total Gains Per Share---0.106-0.169+59%-0.051-52%-0.124+17%-0.142+34%-0.014-86%
Usd Book Value---16904240.000-7613720.000-55%8805820.000-292%8521986.667-298%26064808.000-165%33024021.176-151%
Usd Book Value Change Per Share---0.106-0.169+59%-0.051-52%-0.124+17%-0.142+34%-0.014-86%
Usd Book Value Per Share---0.490-0.221-55%0.255-292%0.247-298%0.755-165%0.957-151%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---21448270.000-15022504.185-30%-42643340.000+99%-28140384.062+31%16119457.683-233%38461370.448-156%
Usd Eps---0.048-0.159+230%-0.071+48%-0.132+174%-0.142+194%-0.039-19%
Usd Free Cash Flow--3447920.000411340.000+738%-1983340.000+158%-2058446.667+160%-4201432.000+222%-2335190.588+168%
Usd Free Cash Flow Per Share--0.1000.012+738%-0.057+158%-0.060+160%-0.122+222%-0.110+210%
Usd Free Cash Flow To Equity Per Share--0.1000.012+738%-0.117+217%-0.085+186%-0.106+207%-0.105+205%
Usd Market Cap50895170.0000%50895170.00060556635.815-16%37955720.000+34%55380849.272-8%100793141.683-50%94165706.814-46%
Usd Price Per Share1.4750%1.4751.755-16%1.100+34%1.605-8%2.921-50%2.729-46%
Usd Profit---1666320.000-5499380.000+230%-1923080.000+15%-4378020.000+163%-4794600.000+188%-1290581.176-23%
Usd Revenue--15321760.00015641400.000-2%16220420.000-6%16066713.333-5%15996148.000-4%16654569.412-8%
Usd Total Gains Per Share---0.106-0.169+59%-0.051-52%-0.124+17%-0.142+34%-0.014-86%
 EOD+0 -0MRQTTM+19 -15YOY+21 -133Y+22 -125Y+20 -1410Y+12 -22

3.3 Fundamental Score

Let's check the fundamental score of Orexo AB ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.636
Price to Book Ratio (EOD)Between0-1-3.011
Net Profit Margin (MRQ)Greater than0-0.109
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.787
Current Ratio (MRQ)Greater than11.731
Debt to Asset Ratio (MRQ)Less than11.305
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.030
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Orexo AB ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.942
Ma 20Greater thanMa 501.475
Ma 50Greater thanMa 1001.475
Ma 100Greater thanMa 2001.486
OpenGreater thanClose1.475
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Orexo AB ADR

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2025-07-02 00:45:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Orexo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -10.9%Β means thatΒ $-0.11 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Orexo AB ADR:

  • The MRQ is -10.9%. The company is making a huge loss. -2
  • The TTM is -34.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-34.3%+23.5%
TTM-34.3%YOY-11.7%-22.6%
TTM-34.3%5Y-30.1%-4.3%
5Y-30.1%10Y-11.1%-19.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Orexo is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -3.0% Return on Assets means thatΒ Orexo generatedΒ $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Orexo AB ADR:

  • The MRQ is -3.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-8.3%+5.3%
TTM-8.3%YOY-2.2%-6.1%
TTM-8.3%5Y-4.7%-3.6%
5Y-4.7%10Y-1.7%-2.9%
4.3.1.3. Return on Equity

Shows how efficient Orexo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Orexo generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Orexo AB ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-37.1%+37.1%
TTM-37.1%YOY-23.1%-14.0%
TTM-37.1%5Y-22.3%-14.8%
5Y-22.3%10Y-10.5%-11.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Orexo AB ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Orexo is operatingΒ .

  • Measures how much profit Orexo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Orexo AB ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-5.1%+5.1%
TTM-5Y-16.7%+16.7%
5Y-16.7%10Y-2.6%-14.1%
4.3.2.2. Operating Ratio

Measures how efficient Orexo is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Orexo AB ADR:

  • The MRQ is 1.177. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.360. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.177TTM1.360-0.183
TTM1.360YOY1.206+0.155
TTM1.3605Y1.386-0.026
5Y1.38610Y1.192+0.194
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Orexo AB ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Orexo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.73Β means the company has $1.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Orexo AB ADR:

  • The MRQ is 1.731. The company is able to pay all its short-term debts. +1
  • The TTM is 1.782. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.731TTM1.782-0.051
TTM1.782YOY1.493+0.289
TTM1.7825Y2.007-0.225
5Y2.00710Y2.071-0.063
4.4.3.2. Quick Ratio

Measures if Orexo is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.79Β means the company can pay off $0.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Orexo AB ADR:

  • The MRQ is 0.787. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.907. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.787TTM0.907-0.120
TTM0.907YOY0.692+0.214
TTM0.9075Y0.821+0.086
5Y0.82110Y0.706+0.114
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Orexo AB ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OrexoΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Orexo to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.30Β means that Orexo assets areΒ financed with 130.5% credit (debt) and the remaining percentage (100% - 130.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Orexo AB ADR:

  • The MRQ is 1.305. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.131. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.305TTM1.131+0.174
TTM1.131YOY0.903+0.228
TTM1.1315Y0.817+0.314
5Y0.81710Y0.746+0.071
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Orexo is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Orexo AB ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.739-7.739
TTM7.739YOY9.951-2.212
TTM7.7395Y5.121+2.618
5Y5.12110Y3.798+1.323
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Orexo generates.

  • Above 15 is considered overpriced butΒ always compareΒ Orexo to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.64 means the investor is paying $-7.64Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Orexo AB ADR:

  • The EOD is -7.636. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.636. Based on the earnings, the company is expensive. -2
  • The TTM is -4.217. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.636MRQ-7.6360.000
MRQ-7.636TTM-4.217-3.419
TTM-4.217YOY-5.778+1.561
TTM-4.2175Y-6.442+2.225
5Y-6.44210Y-1.408-5.034
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Orexo AB ADR:

  • The EOD is 3.690. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.690. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.978. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.690MRQ3.6900.000
MRQ3.690TTM0.978+2.712
TTM0.978YOY-11.493+12.471
TTM0.9785Y-4.135+5.113
5Y-4.13510Y-2.158-1.976
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Orexo is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -3.01 means the investor is paying $-3.01Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Orexo AB ADR:

  • The EOD is -3.011. Based on the equity, the company is expensive. -2
  • The MRQ is -3.011. Based on the equity, the company is expensive. -2
  • The TTM is 0.762. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-3.011MRQ-3.0110.000
MRQ-3.011TTM0.762-3.773
TTM0.762YOY5.132-4.370
TTM0.7625Y3.073-2.311
5Y3.07310Y2.526+0.548
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets529,000
Total Liabilities690,300
Total Stockholder Equity-161,300
 As reported
Total Liabilities 690,300
Total Stockholder Equity+ -161,300
Total Assets = 529,000

Assets

Total Assets529,000
Total Current Assets355,800
Long-term Assets173,200
Total Current Assets
Cash And Cash Equivalents 119,100
Net Receivables 161,800
Inventory 36,200
Total Current Assets  (as reported)355,800
Total Current Assets  (calculated)317,100
+/- 38,700
Long-term Assets
Property Plant Equipment 85,300
Long-term Assets  (as reported)173,200
Long-term Assets  (calculated)85,300
+/- 87,900

Liabilities & Shareholders' Equity

Total Current Liabilities205,600
Long-term Liabilities484,700
Total Stockholder Equity-161,300
Total Current Liabilities
Accounts payable 39,900
Other Current Liabilities 11,400
Total Current Liabilities  (as reported)205,600
Total Current Liabilities  (calculated)51,300
+/- 154,300
Long-term Liabilities
Long term Debt 460,800
Capital Lease Obligations Min Short Term Debt23,100
Long-term Liabilities  (as reported)484,700
Long-term Liabilities  (calculated)483,900
+/- 800
Total Stockholder Equity
Total Stockholder Equity (as reported)-161,300
Total Stockholder Equity (calculated)0
+/- 161,300
Other
Net Debt 341,700
Net Invested Capital 299,500
Net Working Capital 150,200
Property Plant and Equipment Gross 85,300



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
112,100
104,800
976,200
1,033,300
1,003,900
1,035,400
1,173,500
1,208,300
1,286,700
1,367,400
1,440,100
1,545,300
1,501,100
1,550,400
1,463,000
1,328,200
1,232,900
1,433,500
1,344,900
1,312,100
1,273,700
1,205,700
1,271,000
1,203,500
1,109,000
949,300
926,900
869,000
786,600
829,900
773,300
697,000
594,800
529,000
529,000594,800697,000773,300829,900786,600869,000926,900949,3001,109,0001,203,5001,271,0001,205,7001,273,7001,312,1001,344,9001,433,5001,232,9001,328,2001,463,0001,550,4001,501,1001,545,3001,440,1001,367,4001,286,7001,208,3001,173,5001,035,4001,003,9001,033,300976,200104,800112,100
   > Total Current Assets 
91,800
85,100
805,000
850,800
827,400
860,800
997,800
994,400
1,059,500
1,065,900
1,138,700
1,236,400
1,221,200
1,243,000
1,057,000
927,200
831,600
1,024,500
943,900
892,900
865,500
813,400
882,000
827,700
735,500
589,300
568,700
518,100
458,900
513,000
466,400
414,400
446,400
355,800
355,800446,400414,400466,400513,000458,900518,100568,700589,300735,500827,700882,000813,400865,500892,900943,9001,024,500831,600927,2001,057,0001,243,0001,221,2001,236,4001,138,7001,065,9001,059,500994,400997,800860,800827,400850,800805,00085,10091,800
       Cash And Cash Equivalents 
31,100
28,100
294,300
370,700
327,900
437,500
494,800
516,600
589,800
647,400
697,000
812,900
816,800
861,400
677,200
593,300
505,300
725,500
679,700
588,100
504,100
437,800
244,200
122,400
132,200
142,400
251,100
184,200
171,000
198,000
139,700
114,900
123,300
119,100
119,100123,300114,900139,700198,000171,000184,200251,100142,400132,200122,400244,200437,800504,100588,100679,700725,500505,300593,300677,200861,400816,800812,900697,000647,400589,800516,600494,800437,500327,900370,700294,30028,10031,100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
223,500
321,500
219,600
136,500
0
0
0
0
0
0
0
0
00000000136,500219,600321,500223,5000000000000000000000000
       Net Receivables 
20,300
21,500
217,800
208,000
245,200
217,200
308,800
297,300
292,000
252,200
291,100
286,400
261,100
241,600
253,600
213,200
207,500
190,200
168,500
211,500
256,700
298,000
329,900
295,100
246,500
245,700
250,500
269,300
197,600
243,300
257,500
245,200
198,500
161,800
161,800198,500245,200257,500243,300197,600269,300250,500245,700246,500295,100329,900298,000256,700211,500168,500190,200207,500213,200253,600241,600261,100286,400291,100252,200292,000297,300308,800217,200245,200208,000217,80021,50020,300
       Inventory 
37,900
35,500
292,900
272,100
250,200
206,100
194,200
180,500
173,600
166,400
150,600
137,000
131,800
140,100
126,200
120,700
108,400
108,800
95,700
93,400
92,300
77,600
84,400
88,700
74,600
64,700
67,100
64,600
42,400
71,700
69,200
54,300
60,100
36,200
36,20060,10054,30069,20071,70042,40064,60067,10064,70074,60088,70084,40077,60092,30093,40095,700108,800108,400120,700126,200140,100131,800137,000150,600166,400173,600180,500194,200206,100250,200272,100292,90035,50037,900
       Other Current Assets 
2,500
0
0
0
0
0
0
0
0
-100
0
100
100
-100
0
0
100
0
0
-100
-100
0
0
0
100
0
0
0
200
0
0
0
-100
0
0-100000200000100000-100-1000010000-1001001000-100000000002,500
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
301,500
301,400
309,000
279,900
307,300
406,000
401,000
401,300
409,000
401,000
419,200
408,200
392,200
389,000
375,800
373,500
360,000
358,200
350,900
327,700
316,900
306,900
282,600
148,400
173,200
173,200148,400282,600306,900316,900327,700350,900358,200360,000373,500375,800389,000392,200408,200419,200401,000409,000401,300401,000406,000307,300279,900309,000301,400301,500000000000
       Property Plant Equipment 
2,400
2,400
20,800
20,000
20,100
19,400
20,300
19,500
20,000
87,700
84,900
84,000
79,000
101,000
93,600
106,200
115,100
119,200
124,300
123,600
125,100
123,200
121,600
116,900
122,100
112,200
115,400
114,500
105,600
99,900
98,500
89,600
81,000
85,300
85,30081,00089,60098,50099,900105,600114,500115,400112,200122,100116,900121,600123,200125,100123,600124,300119,200115,100106,20093,600101,00079,00084,00084,90087,70020,00019,50020,30019,40020,10020,00020,8002,4002,400
       Long Term Investments 
0
0
0
7,000
7,100
7,300
7,800
7,700
10,400
10,800
10,800
12,300
1,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,40012,30010,80010,80010,4007,7007,8007,3007,1007,000000
       Intangible Assets 
15,200
15,000
129,800
125,400
121,000
116,600
112,100
108,300
103,900
99,700
95,500
101,900
114,000
0
0
0
234,300
0
0
0
248,800
0
0
0
217,400
0
0
0
173,200
0
0
0
26,800
0
026,800000173,200000217,400000248,800000234,300000114,000101,90095,50099,700103,900108,300112,100116,600121,000125,400129,80015,00015,200
       Other Assets 
0
21,100
20,600
30,100
28,300
31,300
35,500
78,400
92,900
103,300
110,200
110,700
85,600
95,000
98,100
54,400
32,700
35,800
25,300
34,200
33,400
26,600
31,000
28,300
0
40,600
0
50,000
0
0
0
0
0
0
00000050,000040,600028,30031,00026,60033,40034,20025,30035,80032,70054,40098,10095,00085,600110,700110,200103,30092,90078,40035,50031,30028,30030,10020,60021,1000
> Total Liabilities 
78,000
74,200
700,400
733,300
674,800
730,000
812,200
783,900
810,600
870,800
887,200
873,600
794,700
775,100
727,500
708,800
674,400
898,700
885,500
900,400
924,100
876,200
962,100
905,100
915,100
820,200
803,100
777,000
727,700
768,500
749,100
724,200
721,100
690,300
690,300721,100724,200749,100768,500727,700777,000803,100820,200915,100905,100962,100876,200924,100900,400885,500898,700674,400708,800727,500775,100794,700873,600887,200870,800810,600783,900812,200730,000674,800733,300700,40074,20078,000
   > Total Current Liabilities 
34,100
36,100
699,800
730,000
349,900
404,800
488,500
457,100
483,400
496,900
516,000
537,900
461,000
461,600
444,500
407,000
601,300
344,600
340,300
356,600
380,200
339,500
431,100
375,300
385,900
305,700
304,000
309,700
263,200
749,200
263,600
244,300
231,100
205,600
205,600231,100244,300263,600749,200263,200309,700304,000305,700385,900375,300431,100339,500380,200356,600340,300344,600601,300407,000444,500461,600461,000537,900516,000496,900483,400457,100488,500404,800349,900730,000699,80036,10034,100
       Short-term Debt 
0
339,400
340,000
340,600
319,100
319,500
319,800
0
0
19,900
196,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000196,90019,90000319,800319,500319,100340,600340,000339,4000
       Short Long Term Debt 
0
339,400
340,000
340,600
319,100
319,500
319,800
0
0
19,900
196,900
0
0
0
0
0
224,500
154,900
0
0
0
0
0
0
0
0
0
0
0
497,800
0
114,500
0
0
00114,5000497,80000000000000154,900224,50000000196,90019,90000319,800319,500319,100340,600340,000339,4000
       Accounts payable 
14,900
0
0
0
45,500
0
0
0
47,700
0
0
0
49,400
0
0
0
47,000
0
0
0
49,200
0
0
0
86,600
0
0
0
36,500
0
0
0
41,500
39,900
39,90041,50000036,50000086,60000049,20000047,00000049,40000047,70000045,50000014,900
       Other Current Liabilities 
19,200
36,100
359,800
182,200
14,200
143,200
180,600
191,100
4,900
190,500
-100
234,400
4,700
157,500
194,800
186,900
6,200
154,900
146,200
192,500
13,300
172,400
249,200
193,000
17,400
283,500
138,100
288,400
6,100
92,200
115,900
100
5,200
11,400
11,4005,200100115,90092,2006,100288,400138,100283,50017,400193,000249,200172,40013,300192,500146,200154,9006,200186,900194,800157,5004,700234,400-100190,5004,900191,100180,600143,20014,200182,200359,80036,10019,200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
373,900
371,200
335,700
333,700
313,500
283,000
301,800
73,100
554,100
545,200
543,800
543,900
536,700
531,000
529,800
529,200
514,500
499,100
467,300
464,500
19,300
485,500
479,900
490,000
484,700
484,700490,000479,900485,50019,300464,500467,300499,100514,500529,200529,800531,000536,700543,900543,800545,200554,10073,100301,800283,000313,500333,700335,700371,200373,900000000000
       Capital Lease Obligations Min Short Term Debt
0
-339,400
-340,000
-340,600
-319,100
-319,500
-319,800
0
0
45,300
-134,100
59,800
54,700
74,400
68,600
63,300
66,500
63,200
63,400
61,100
58,200
54,000
50,800
47,800
44,800
41,300
36,100
30,900
25,400
24,200
24,500
20,100
16,000
23,100
23,10016,00020,10024,50024,20025,40030,90036,10041,30044,80047,80050,80054,00058,20061,10063,40063,20066,50063,30068,60074,40054,70059,800-134,10045,30000-319,800-319,500-319,100-340,600-340,000-339,4000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
-100
100
0
100
0
-100
0
0
100
100
0
100
100
0
0
0
200
0
-100
100
0
0
-100
0
0
00-10000100-1000200000100100010010000-10001000100-100000000000
> Total Stockholder Equity
34,200
30,600
275,800
300,000
329,100
305,400
361,300
424,400
476,100
496,600
552,900
671,700
706,400
775,300
735,500
619,400
558,500
534,800
459,400
411,700
349,600
329,500
308,900
298,400
193,900
129,100
123,800
92,000
58,900
61,400
24,200
-27,200
-126,300
-161,300
-161,300-126,300-27,20024,20061,40058,90092,000123,800129,100193,900298,400308,900329,500349,600411,700459,400534,800558,500619,400735,500775,300706,400671,700552,900496,600476,100424,400361,300305,400329,100300,000275,80030,60034,200
   Common Stock
1,500
273,300
275,800
300,000
14,100
305,400
361,300
424,400
14,200
496,600
552,900
671,700
14,200
775,300
735,500
619,400
14,200
534,800
459,400
411,700
14,200
329,500
308,900
298,400
0
129,100
0
92,000
0
0
0
0
0
0
00000092,0000129,1000298,400308,900329,50014,200411,700459,400534,80014,200619,400735,500775,30014,200671,700552,900496,60014,200424,400361,300305,40014,100300,000275,800273,3001,500
   Retained Earnings Total Equity0000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
-7,300
0
0
0
-300
0
0
0
3,100
0
0
0
-13,400
0
0
0
-400
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000-400000-13,4000003,100000-300000-7,3000000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue590,000
Cost of Revenue-72,100
Gross Profit517,900517,900
 
Operating Income (+$)
Gross Profit517,900
Operating Expense-736,500
Operating Income-146,500-218,600
 
Operating Expense (+$)
Research Development340,000
Selling General Administrative357,000
Selling And Marketing Expenses-
Operating Expense736,500697,000
 
Net Interest Income (+$)
Interest Income7,300
Interest Expense-60,000
Other Finance Cost-400
Net Interest Income-52,300
 
Pretax Income (+$)
Operating Income-146,500
Net Interest Income-52,300
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-190,600-146,500
EBIT - interestExpense = -60,000
-203,000
-143,000
Interest Expense60,000
Earnings Before Interest and Taxes (EBIT)--130,600
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-190,600
Tax Provision-12,400
Net Income From Continuing Ops-203,000-203,000
Net Income-203,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-52,300
 

Technical Analysis of Orexo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Orexo. The general trend of Orexo is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Orexo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Orexo Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Orexo AB ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.475 < 1.475 < 1.475.

The bearish price targets are: 1.475 > 1.475 > 1.475.

Know someone who trades $ORXOY? Share this with them.πŸ‘‡

Orexo AB ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Orexo AB ADR. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Orexo AB ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Orexo AB ADR. The current macd is -0.00018902.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orexo price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Orexo. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Orexo price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Orexo AB ADR Daily Moving Average Convergence/Divergence (MACD) ChartOrexo AB ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Orexo AB ADR. The current adx is 54.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Orexo shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Orexo AB ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Orexo AB ADR. The current sar is 1.54689079.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Orexo AB ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Orexo AB ADR. The current rsi is 22.94. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Orexo AB ADR Daily Relative Strength Index (RSI) ChartOrexo AB ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Orexo AB ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Orexo price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Orexo AB ADR Daily Stochastic Oscillator ChartOrexo AB ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Orexo AB ADR. The current cci is -66.66666667.

Orexo AB ADR Daily Commodity Channel Index (CCI) ChartOrexo AB ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Orexo AB ADR. The current cmo is -77.82870519.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Orexo AB ADR Daily Chande Momentum Oscillator (CMO) ChartOrexo AB ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Orexo AB ADR. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Orexo AB ADR Daily Williams %R ChartOrexo AB ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Orexo AB ADR.

Orexo AB ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Orexo AB ADR. The current atr is 0.000035.

Orexo AB ADR Daily Average True Range (ATR) ChartOrexo AB ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Orexo AB ADR. The current obv is 7,800.

Orexo AB ADR Daily On-Balance Volume (OBV) ChartOrexo AB ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Orexo AB ADR. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Orexo AB ADR Daily Money Flow Index (MFI) ChartOrexo AB ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Orexo AB ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Orexo AB ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Orexo AB ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.942
Ma 20Greater thanMa 501.475
Ma 50Greater thanMa 1001.475
Ma 100Greater thanMa 2001.486
OpenGreater thanClose1.475
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Orexo with someone you think should read this too:
  • Are you bullish or bearish on Orexo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Orexo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Orexo AB ADR

I send you an email if I find something interesting about Orexo AB ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Orexo AB ADR.

Receive notifications about Orexo AB ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.